Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nydia Burgos-Ortega"'
Autor:
Laurianne E Musa-Penna, Yadiel Rivera-Nieves, Nicole Hernandez-Cordero, Nydia Burgos-Ortega, Luis Madera-Marin, Alexandra Rosado-Burgos, Monica Ortiz-Rivera, Margarita Ramirez-Vick, Loida Gonzalez-Rodriguez, Milliete Alvarado-Santiago
Publikováno v:
Journal of the Endocrine Society. 6:A871-A872
Background Giant cell tumor of bone (GCTB) is a skeletal neoplasm that most commonly occurs in long bones and rarely in the skull. These tumors are considered benign but tend to be locally aggressive and carry a high rate of local recurrence. True ma
Autor:
Laurianne El Musa Penna, Mónica Ortiz Rivera, Alexandra Rosado Burgos, Luis Madera Marin, Yadiel Rivera Nieves, Nicole Hernandez Cordero, Nydia Burgos Ortega, Milliete Alvarado, Margarita Ramirez-Vick, Loida Gonzalez Rodríguez
Publikováno v:
Journal of the Endocrine Society. 6:A333-A334
Introduction Sodium-glucose cotransporter type 2 inhibitors (SGLT2-i) have proven to be a gamechanger for patients with diabetes, cardiovascular, and renal disease. However, this class of medications confers an increased risk for adverse side effects
Autor:
Luis Madera Marin, Yadiel Rivera Nieves, Monica Ortiz Rivera, Alexandra Rosado Burgos, Nicole Hernandez Cordero, Nydia Burgos Ortega, Margarita Ramirez Vick, Loida Gonzalez Rodriguez, Milliete Alvarado
Publikováno v:
Journal of the Endocrine Society. 6:A504-A505
Introduction Cushing's Disease (CD) denotes a pathologic endogenous hypercortisolism secondary to excessive adrenocorticotropic hormone (ACTH) production. Cushing Disease is a rare condition with an estimated incidence of approximately 1.2-1.4 new ca
Autor:
Nicole Hernandez-Cordero, Yadiel Rivera-Nieves, Nydia Burgos-Ortega, Alexandra Rosado-Burgos, Monica Ortiz-Rivera, Luis Madera-Marin, Loida Gonzalez-Rodriguez, Milliette Alvarado-Santiago, Margarita Ramirez-Vick
Publikováno v:
Journal of the Endocrine Society. 6:A505-A506
Background Breakthroughs in oncology have led to the incorporation of immunotherapy to improve the prognosis in patients with advanced malignancies. Checkpoint inhibitors are immunomodulatory antibodies that enhance the immune system using PD-1/PD-L1
Autor:
Alexandra Rosado-Burgos, Yadiel Rivera Nieves, Nicole Hernandez Cordero, Monica Ortiz Rivera, Luis Madera Marin, Nydia Burgos Ortega, Margarita Ramirez Vick, Loida Gonzalez Rodriguez, Milliete Alvarado, Laurianne El Musa-Penna
Publikováno v:
Journal of the Endocrine Society. 6:A174-A174
Introduction Primary hyperparathyroidism (HPT) is characterized by an overproduction of parathyroid hormone (PTH) by a parathyroid adenoma, parathyroid hyperplasia, or parathyroid carcinoma classically causing hypercalcemia. Incidence of this patholo
Autor:
Monica Ortiz-Rivera, Nydia Burgos Ortega, Luis Madera-Marin, Alexandra Rosado Burgos, Nicole Hernandez Cordero, Laurianne E Musa-Pena, Yadiel Rivera Nieves, Margarita Ramirez Vick, Milliette Alvarado Santiago, Loida Gonzalez Rodriguez
Publikováno v:
Journal of the Endocrine Society. 6:A52-A52
Introduction Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal glands, but often presents an aggressive behavior with variable prognosis. Median age of diagnosis is in the fifth to sixth decade of life with a median survival rate of